Molecular mechanisms of the exaggerated growth of vascular smooth muscle cells in hypertension
- PMID: 9638516
- DOI: 10.5551/jat1994.4.65
Molecular mechanisms of the exaggerated growth of vascular smooth muscle cells in hypertension
Abstract
The molecular mechanisms of the exaggerated growth of vascular smooth muscle cells (VSMC) in hypertension are reviewed based on our previous experimental data. Spontaneously hypertensive rats (SHR)-derived VSMC increasingly express angiotensinogen, cathepsin D and angiotensin-converting enzyme (ACE) mRNAs, compared to cells from normotensive Wistar-Kyoto (WKY) rats, indicating the presence of an Ang II generating system in a homogeneous culture of VSMC from SHR. The produced Ang II then induces TGF-beta. SHR-derived VSMC show the distinct expression and abnormal regulation by Ang II of TGF-beta receptors when compared with cells from WKY rats, which express TGF-beta type II receptor predominantly to induce PDGF A-chain stimulation of VSMC growth. These findings imply that the increased growth of VSMC in hypertension is a primary event independent of high blood pressure, and is associated with endogenous Ang II-related growth factors.
Similar articles
-
Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats.J Cardiovasc Pharmacol. 2001 Jan;37(1):108-18. doi: 10.1097/00005344-200101000-00013. J Cardiovasc Pharmacol. 2001. PMID: 11152368
-
Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II.Hypertension. 1998 Feb;31(2):672-7. doi: 10.1161/01.hyp.31.2.672. Hypertension. 1998. PMID: 9461239
-
Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats.Arterioscler Thromb Vasc Biol. 1999 May;19(5):1210-7. doi: 10.1161/01.atv.19.5.1210. Arterioscler Thromb Vasc Biol. 1999. PMID: 10323771
-
[Suppression of the exaggerated growth of vascular smooth muscle cells from SHR by antisense oligodeoxynucleotide to TGF beta].Nihon Rinsho. 1993 Jun;51(6):1663-7. Nihon Rinsho. 1993. PMID: 8320846 Review. Japanese.
-
Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.J Cardiovasc Pharmacol. 1993;22 Suppl 6:S64-74. J Cardiovasc Pharmacol. 1993. PMID: 7508064 Review.
Cited by
-
Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.Immunology. 2006 May;118(1):10-24. doi: 10.1111/j.1365-2567.2006.02336.x. Immunology. 2006. PMID: 16630019 Free PMC article. Review.
-
JOSD2 inhibits angiotensin II-induced vascular remodeling by deubiquitinating and stabilizing SMAD7.Acta Pharmacol Sin. 2025 May;46(5):1275-1288. doi: 10.1038/s41401-024-01437-y. Epub 2025 Jan 20. Acta Pharmacol Sin. 2025. PMID: 39833306
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous